Ann: Recce Pharmaceuticals Receives Innovation Connections Grant, page-2

ASX Announcement
Recce Pharmaceuticals Receives
Entrepreneurs’ Programme Innovation Connections Grant
• Recce awarded grant of A$37,508 plus GST by the Australian Government Department
of Industry, Science, Energy and Resources as part of the Entrepreneurs’ Programme.
• The grant will be directed towards project costs associated with assessing RECCE®
327 in the SARS-CoV-2 Antiviral Screening Program and is subject to performance
based milestones.
• The Company will receive a follow up grant of a maximum of $50,000 upon
successful completion of milestones.
Sydney Australia, 1 September 2020: Recce Pharmaceuticals Ltd (ASX: RCE) (Company),
the Company developing new classes of synthetic anti-infectives, today announced it has
received an Innovation Connections grant of A$37,508 plus Goods and Services Tax (GST),
under the Australian Government’s Entreprenuers’ Programme.
RECCE® 327 was recently accepted into the SARS-CoV-2 Antiviral Screening Program, a feefor-service research program being conducted at the Doherty Institute (a joint venture partnership
between the University of Melbourne and The Royal Melbourne Hospital) and CSIRO’s Australian
Centre for Disease Preparedness (ACDP).
Innovation Connections, assists businesses in establishing research priorities, locating
researchers, and providing access to funding to enable R&D projects.
All intellectual property rights are retained by the Company, with the full program expected to
take some months and updates to be made available on material developments as the program
advances.
Non-Executive Chairman Dr. John Prendergast said, “We are very pleased to receive this funding
from the Australian Government Entrepreneurs’ Programme to study the efficacy of RECCE® 327
against SARS-CoV-2. The funds will go towards testing of our lead compound and enable us to
advance a new class of anti-infectives with a unique mechanism of action against hyper-mutation
to address the growing threat posed by resistant superbugs and viruses.”